F869-0647 Screening compound: N-CYCLOHEPTYL-1-[2-(4-METHYLPHENYL)-4-PYRIMIDINYL]-4-PIPERIDINECARBOXAMIDE

F869-0647 Screening compound: N-CYCLOHEPTYL-1-[2-(4-METHYLPHENYL)-4-PYRIMIDINYL]-4-PIPERIDINECARBOXAMIDE
F869-0647 Screening compound: N-CYCLOHEPTYL-1-[2-(4-METHYLPHENYL)-4-PYRIMIDINYL]-4-PIPERIDINECARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound F869-0647
N-CYCLOHEPTYL-1-[2-(4-METHYLPHENYL)-4-PYRIMIDINYL]-4-PIPERIDINECARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F869-0647

Molecular Formula

C24H32N4O (C24 H32 N4 O)

Compound Name

N-CYCLOHEPTYL-1-[2-(4-METHYLPHENYL)-4-PYRIMIDINYL]-4-PIPERIDINECARBOXAMIDE

IUPAC name

n/a

SMILES

Cc(cc1)ccc1-c1nccc(N(CC2)CCC2C(NC2CCCCCC2)=O)n1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

392.54

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.161

Distribution Coefficient, logD

5.140

Water Solubility, LogSw

-4.90

Polar Surface Area

46.356

Acid Dissociation Constant (pKa)

14.37

Base Dissociation Constant (pKb)

6.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.00

F869-0647 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with F869-0647 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F869-0647?
Check Price and Availability of F869-0647, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F869-0647 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F869-0647
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F869-0647
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F869-0647 available by request